FierceBiotech

FDA clears Baxter's in-hospital dialysis machine, cementing emergency COVID authorization

In comparison to the flood of emergency use authorizations doled out by the FDA throughout the COVID-19 pandemic, the number of those tests and devices that have gone on to receive full, non-pandemic ...
Business Wire

Baxter Obtains U.S. FDA Emergency Use Authorization for Regiocit Replacement Solution Used in CRRT

Baxter continues to provide CRRT machines, fluids and sets to help healthcare facilities address patient needs around the world. Baxter has received EUAs for several of its products used in CRRT, ...
Business Wire

Baxter Obtains U.S. FDA Emergency Use Authorizations for HF20 Set and ST Set Used in CRRT During Covid-19 Pandemic

Baxter continues to provide CRRT machines, fluids and sets to help healthcare facilities address patient needs around the world. In April, Baxter received EUA from the FDA for its Oxiris filter set.
Nasdaq

Baxter (BAX) Receives EUA for Regiocit Replacement Solution

Baxter International Inc. BAX recently received Emergency Use Authorization (EUA) from the FDA for Regiocit, which is the only authorized citrate-based replacement solution available in the United ...
Nasdaq

Baxter's (BAX) PrisMax 2 to Simplify Organ Support Therapies

Baxter International Inc. BAX recently announced the global launch of the latest version of its next-generation platform, PrisMax 2. The PrisMax 2 system aims to help streamline the delivery of ...
Healio

Baxter begins clinical trial of citrate anticoagulant for use during CRRT

Please provide your email address to receive an email when new articles are posted on . Baxter International Inc. has started a Phase 3 clinical trial evaluating an investigational drug that combines ...
FierceBiotech

FDA clears Baxter's connected, in-center dialysis machine

Baxter has received an FDA clearance for its latest, portable dialysis machine designed to connect directly with electronic medical records for patients’ prescriptions and treatment data. The ...